http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Kim, S.T.,Banks, K.C.,Pectasides, E.,Kim, S.Y.,Kim, K.,Lanman, R.B.,Talasaz, A.,An, J.,Choi, M.G.,Lee, J.H.,Sohn, T.S.,Bae, J.M.,Kim, S.,Park, S.H.,Park, J.O.,Park, Y.S.,Lim, H.Y.,Kim, N.K.D.,Park, W. Elsevier 2018 Annals of oncology Vol.29 No.4
<P>Conclusions: The present study showed that HER2+GC patients respond differently according to concomitant genomic aberrations beyond ERBB2, high ERBB2 amplification by NGS or cfDNA can be a positive predictor for patient selection, and tumor genomic alterations change significantly during targeted agent therapy.</P>